Home Featured

Featured

Random

PT440 – Coming Back to Stillness, Microdosing and Adaptogens, and What We Can Learn From Autism

Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber;...

Revive Therapeutics Ltd. Expands Life Offering to Quebec

Psyched Wellness Receives DTC Eligibility

The Future of MDMA Therapy: Promising Next Steps

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...

Psychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications;...

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing...

MindMed Announces Transitions to Management Team

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with...

Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge...

Natural Medicine Advisory Bulletin 9

Wesana Announces Sale of Clinic Management Services Organization

12 3...308 Page 1 of 308

EDITOR PICKS

Q4’25 Psychedelic Lobbying Update

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

PT440 – Coming Back to Stillness, Microdosing and Adaptogens, and What We Can Learn From Autism

Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber;...

Revive Therapeutics Ltd. Expands Life Offering to Quebec

Psyched Wellness Receives DTC Eligibility

The Future of MDMA Therapy: Promising Next Steps

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...

Psychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications;...

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing...

MindMed Announces Transitions to Management Team

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with...

Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge...

Natural Medicine Advisory Bulletin 9

Wesana Announces Sale of Clinic Management Services Organization

EDITOR PICKS

Q4’25 Psychedelic Lobbying Update

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY